Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Institutional Investors, Proxies Rally Against EpiPen Board
Government

Institutional Investors, Proxies Rally Against EpiPen Board

by ai-cio.com posted 1year ago 408 views
Backed by proxy firms Glass Lewis and Institutional Shareholder Services (ISS), New York City Pension Funds and a group of institutional investors told EpiPen maker Mylan’s shareholders Monday to air their grievances —in paper form— with the allergy treatment company’s board of directors and its chairman’s pay at Mylan’s June 22 shareholder meeting.